Meanwhile, the treatment of HF with EMPG is accompanied by the increase in PPARα, RXRα, and CPT1α metabolic pathway proteins, and this process can be visualized by 18F-FDG PET/CT imaging. This evidence concerns the gene CPT1A and hydrops fetalis.